Pan Degenerate Amplification and Adaptation (PANDAA™) uniquely enables real-time PCR for target detection in highly variable genomic regions.

Contact Us

change@aldatubio.com

News

Aldatu Enables On-site COVID-19 Testing at Major Boston Hospital
March 19th, 2020
Aldatu Biosciences Expands PANDAA Platform Beyond HIV with SBIR for the First Pan-Lineage Lassa Fever Test
April 29th, 2019
Aldatu Biosciences Awarded $3 Million NIH SBIR Contract for Early HIV Drug Resistance Detection
October 15th, 2018
Aldatu Biosciences announces addition of Michael Henry and Marta Fernández Suárez to the Scientific and Business Advisory Board
August 3rd, 2017